1. Home
  2. MAZE vs GCI Comparison

MAZE vs GCI Comparison

Compare MAZE & GCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAZE
  • GCI
  • Stock Information
  • Founded
  • MAZE 2018
  • GCI 1997
  • Country
  • MAZE United States
  • GCI United States
  • Employees
  • MAZE N/A
  • GCI N/A
  • Industry
  • MAZE
  • GCI Newspapers/Magazines
  • Sector
  • MAZE
  • GCI Consumer Discretionary
  • Exchange
  • MAZE NYSE
  • GCI Nasdaq
  • Market Cap
  • MAZE 523.1M
  • GCI 549.7M
  • IPO Year
  • MAZE 2025
  • GCI N/A
  • Fundamental
  • Price
  • MAZE $9.86
  • GCI $3.50
  • Analyst Decision
  • MAZE Strong Buy
  • GCI Buy
  • Analyst Count
  • MAZE 3
  • GCI 3
  • Target Price
  • MAZE $25.67
  • GCI $5.70
  • AVG Volume (30 Days)
  • MAZE 252.2K
  • GCI 2.2M
  • Earning Date
  • MAZE 01-01-0001
  • GCI 05-01-2025
  • Dividend Yield
  • MAZE N/A
  • GCI N/A
  • EPS Growth
  • MAZE N/A
  • GCI N/A
  • EPS
  • MAZE 1.25
  • GCI N/A
  • Revenue
  • MAZE $167,500,000.00
  • GCI $2,509,315,000.00
  • Revenue This Year
  • MAZE N/A
  • GCI N/A
  • Revenue Next Year
  • MAZE N/A
  • GCI N/A
  • P/E Ratio
  • MAZE $7.07
  • GCI N/A
  • Revenue Growth
  • MAZE N/A
  • GCI N/A
  • 52 Week Low
  • MAZE $6.71
  • GCI $2.35
  • 52 Week High
  • MAZE $17.00
  • GCI $5.93
  • Technical
  • Relative Strength Index (RSI)
  • MAZE N/A
  • GCI 58.04
  • Support Level
  • MAZE N/A
  • GCI $2.61
  • Resistance Level
  • MAZE N/A
  • GCI $3.79
  • Average True Range (ATR)
  • MAZE 0.00
  • GCI 0.26
  • MACD
  • MAZE 0.00
  • GCI 0.12
  • Stochastic Oscillator
  • MAZE 0.00
  • GCI 73.39

About MAZE MAZE THERAPEUTICS INC

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.

About GCI Gannett Co. Inc.

Gannett Co Inc is a digital newspaper company providing local media and marketing solutions in the U.S. The group operates in three segments, Domestic Gannett Media, Newsquest, and Digital Marketing Solutions. The majority of revenue is from the Domestic Gannett Media segment. The company's brands include USA TODAY and more than 250 daily newspapers as well as digital marketing services companies, including ReachLocal, WordStream, and others. The company produces more than 350 annual events, such as themed expos. The company also operates in the U.K. through the U.K. media company Newsquest, providing more than 150 local media brands.

Share on Social Networks: